Topics

No keywords indexed for this article. Browse by subject →

References
41
[1]
The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises

Srinivasa N. Raja, Daniel B. Carr, Milton Cohen et al.

Pain 2020 10.1097/j.pain.0000000000001939
[2]
Dureja "Evidence and consensus recommendations for the pharmacological management of pain in India." JPR (2017) 10.2147/jpr.s128655
[3]
Castroman "Reimagining how we treat acute pain: a narrative review." Cureus (2022)
[4]
A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors

Zachary Zimmer, Kathryn Fraser, Hanna Grol-Prokopczyk et al.

Pain 2022 10.1097/j.pain.0000000000002557
[5]
Chronic pain: an update on burden, best practices, and new advances

Steven P Cohen, Lene Vase, William M Hooten

The Lancet 2021 10.1016/s0140-6736(21)00393-7
[6]
AANA Board of Directors. Chronic Pain Management Guidelines by AANA publishing - Issuu. 2021; Available from: https://issuu.com/aanapublishing/docs/2_-_chronic_pain_management_guidelines
[7]
Laycock "Objective assessment of acute pain." J Anesth Clin Res (2016) 10.4172/2155-6148.1000630
[8]
Amaechi "Pharmacologic therapy for acute pain." Am Fam Physician (2021)
[9]
Qaseem "Nonpharmacologic and pharmacologic management of acute pain from non–low back, musculoskeletal injuries in adults: a clinical guideline from the American College of Physicians and American Academy of Family Physicians." Ann Intern Med (2020) 10.7326/m19-3602
[10]
U.S. Department of Health and Human Services. Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. Retrieved from U S Department of Health and Human [Internet] 2019; Available from: https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html
[11]
Bhatnagar "Aspiring pain practitioners in India: assessing challenges and building opportunities." Indian J Palliat Care (2018)
[12]
Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). StatPearls [Internet] 2023; Available from: http://www.ncbi.nlm.nih.gov/books/NBK547742/
[13]
A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Rebekah Brennan, Mayyada Wazaify, Haneen Shawabkeh et al.

Drug Safety 2021 10.1007/s40264-021-01085-9
[14]
McEvoy "Pharmacogenomics of NSAID-induced upper gastrointestinal toxicity." Front Pharmacol (2021) 10.3389/fphar.2021.684162
[15]
Arulrhaj "Effectiveness of nimesulide in acute fever management in adults: retrospective electronic medical records database study outcome in outpatient department." J Assoc Physicians India (2021)
[16]
Tiwaskar "An open-label, prospective, multicentric, cohort study of nimesulide/paracetamol fixed drug combination for acute pain management: sub-group analysis." JAPI (2023) 10.5005/japi-11001-0234
[17]
Kress "Acute pain: a multifaceted challenge – the role of nimesulide." Curr Med Res Opin (2016) 10.1185/03007995.2015.1100986
[18]
Nimesulide - referral | European Medicines Agency (EMA) [Internet]. European Medicines Agency Science Medicines Health 2010; Available from: https://www.ema.europa.eu/en/medicines/human/referrals/nimesulide
[19]
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox [Internet] 2016; Available from: http://www.ncbi.nlm.nih.gov/books/NBK547948/
[20]
Goud "Nimesulide – a drug to be banned completely." Asian J Pharm Res (2021) 10.52711/2231-5691.2021.00025
[21]
Kulkarni "Narrative review of nimesulide in adults: current scenario." Indian J Clin Pract (2022)
[22]
Santos "Preemptive effects of ibuprofen and nimesulide on postoperative pain control after open flap periodontal surgeries: a randomized placebo-controlled split-mouth clinical trial." J Periodontol (2022)
[23]
Caiazzo "The relatively selective cyclooxygenase-2 inhibitor nimesulide: what’s going on?" Eur J Pharmacol (2019) 10.1016/j.ejphar.2019.01.044
[24]
Ho "Perceptions and beliefs regarding NSAIDs in the Asia-Pacific Region." J Pain Res (2020) 10.2147/jpr.s229387
[25]
Chaudhary "Comparison of nimesulide and ketorolac in control of pain, swelling, and trismus following extraction of impacted third molar." JNDA (2020)
[26]
Umurova "Comparative effectiveness of nimesulide and diclofenac sodium in gout." Asian J Pharm Biol Res (2023)
[27]
Tiwaskar "Safety and efficacy of nimesulide/paracetamol fixed-dose combination in acute pain (SAFE study)." Indian J Clin Pract (2022)
[28]
Patil "A comparative analysis of the efficacy and safety of nimesulide/paracetamol fixed-dose combination with other NSAIDs in acute pain management: a randomized, prospective, multicenter, active-controlled study (the SAFE-2 Study)." Cureus (2024)
[29]
Saad J, Mathew D. Nonsteroidal Anti-Inflammatory Drugs Toxicity. StatPearls [Internet] 2023; Available from: http://www.ncbi.nlm.nih.gov/books/NBK526006/
[30]
Meunier "Recent advances in hepatotoxicity of non-steroidal anti-inflammatory drugs." Ann Hepatol (2018) 10.5604/01.3001.0010.8633
[31]
Low "Drug induced liver injury: East versus West – a systematic review and meta-analysis." Clin Mol Hepatol (2020) 10.3350/cmh.2019.1003
[32]
Gupta "Safety of oral use of nimesulide in children: systematic review of randomized controlled trials." Indian Pediatr (2003)
[33]
Monteiro "Safety of non-steroidal anti-inflammatory drugs in the elderly: an analysis of published literature and reports sent to the Portuguese Pharmacovigilance System." Int J Environ Res Public Health (2022) 10.3390/ijerph19063541
[34]
Castellsague "Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)." Drug Saf (2012) 10.1007/bf03261999
[35]
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs

Guillherme Nobre Cavalcanti Lucas, Ana Carla Carneiro Leitão, Renan Lima Alencar et al.

Brazilian Journal of Nephrology 2019 10.1590/2175-8239-jbn-2018-0107
[36]
Scheinberg "Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms." DDDT (2018) 10.2147/dddt.s172068
[37]
Rainsford "Nimesulide—a multifactorial approach to inflammation and pain: scientific and clinical consensus." Curr Med Res Opin (2006) 10.1185/030079906x104849
[38]
Ward "Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states." Drugs (1988) 10.2165/00003495-198836060-00004
[39]
Pochobradsky "Post-marketing survey of nimesulide in the short-term treatment of osteoarthritis." Drugs Exp Clin Res (1991)
[40]
Reiner "Nimesulide and antibiotics in the treatment of acute infections of the respiratory tract." Curr Med Res Opin (1983) 10.1185/03007998309109787
[41]
Gallucci "Nimesulide in the treatment of advanced cancer pain. Double-blind comparison with naproxen." Arzneimittelforschung (1992)
Metrics
4
Citations
41
References
Details
Published
Feb 01, 2025
Vol/Issue
73(3)
Pages
e22-e28
Cite This Article
Mangesh Tiwaskar, Sushant Charde, Nikhil Balankhe, et al. (2025). Nimesulide: Critical Appraisal of Safety and Efficacy in Acute Pain. Journal of the Association of Physicians of India, 73(3), e22-e28. https://doi.org/10.59556/japi.73.0870